Join the Seizures group to help and get support from people like you.
Seizures News (Page 4)
Related terms: Complex Partial Seizure, Fits, Convulsion, Absence Seizure
Maternal Epilepsy Tied to Increased Maternal Morbidity, Perinatal Mortality and Morbidity
FRIDAY, Aug. 16, 2024 – Women with epilepsy have a considerably higher risk for severe maternal and perinatal outcomes and an increased risk for death during pregnancy and postpartum, according to a...
AI Is Helping Doctors Interpret a Crucial Brain Test
WEDNESDAY, July 31, 2024 – Artificial intelligence is adding new luster to the old-fashioned EEG brain scan, increasing the potential usefulness of the century-old medical test, a new report says....
ECT-Induced Seizure Length Tied to Major Depressive Disorder Remission
MONDAY, July 29, 2024 – For patients with major depressive disorder (MDD), seizure duration of 60 to 69 seconds induced by electroconvulsive therapy (ECT) is associated with the highest remission...
Sexual and Gender Minority Adults Have Higher Risk of Epilepsy
WEDNESDAY, July 24, 2024 – Sexual and gender minority adults in the United States have a disproportionate prevalence of epilepsy, according to a study published online July 22 in JAMA Neurology. ...
Scientists May Have Spotted Way to Predict Seizures
MONDAY, July 22, 2024 – The risk of seizures within the next 24 hours can be predicted by watching for abnormal brain activity patterns in people with epilepsy, a new study finds. The storm of brain...
Socioeconomic Deprivation Tied to Higher Risk of Epilepsy Related to TBI
TUESDAY, July 16, 2024 – Socioeconomic deprivation increases the risk for sustaining a traumatic brain injury (TBI), and in some age groups, it may also increase the risk for epilepsy after a TBI,...
Hospital Admissions for Epilepsy Change With Climatic Factors
MONDAY, July 15, 2024 – Changes in climate are possible trigger factors for seizure-related hospitalizations in patients with epilepsy, according to a study published online June 11 in the Journal ...
FDA Approves Libervant (diazepam) Buccal Film for the Treatment of Seizure Clusters in Pediatric Patients Ages 2-5 Years
WARREN, N.J., April 29, 2024 (GLOBE NEWSWIRE) – Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improve...
Xcopri (cenobamate) Receives FDA Approval for Alternate Methods of Administration That Include Crushed Tablet in Liquid Suspension Taken Orally or Through a Nasogastric Tube
PARAMUS, N.J., April 11, 2024 /PRNewswire/ -- SK Life Science, Inc., a U.S. pharmaceutical company developing treatments that will change the future of central nervous system (CNS) disorders and a ...
FDA Approves Sezaby (phenobarbital sodium powder for injection) for the Treatment of Neonatal Seizures
First and only product approved for treating seizures in neonatal patients Mumbai, India, November 18, 2022 – Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Ltd. t...
FDA Approves Zonisade (zonisamide oral suspension) for the Treatment of Partial-Onset Seizures
The first and only FDA-approved zonisamide oral liquid formulation WOBURN, Mass., July 18, 2022 /PRNewswire/ – Azurity Pharmaceuticals, Inc., a private pharmaceutical company focused on developing...
Fintepla (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)
Fintepla® has demonstrated efficacy in the most difficult-to-treat seizure types,1,2 including drop seizures, which cause a person to suddenly lose muscle tone, become limp, and fall to the ground, ...
FDA Approves Ztalmy (ganaxolone) for Seizures Associated with CDKL5 Deficiency Disorder
RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today...
FDA Medwatch Alert: Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Levetiracetam Injection, USP Due to Lack of Sterility Assurance
CHICAGO, IL – November 19, 2021 - Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of four lots of Levetiracetam Injection, USP, to the user level. The lack of container c...
UCB Announces Briviact (brivaracetam) Now FDA-Approved to Treat Partial-Onset Seizures in Pediatric Patients One Month of Age and Older
ATLANTA, Aug. 30, 2021 /PRNewswire/ – UCB announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Briviact (brivaracetam) CV tablets, oral solution,...
Further information
Related condition support groups
Seizure Prevention, Seizure Prophylaxis, Epilepsy
Related drug support groups
gabapentin, clonazepam, Valium, diazepam, Topamax, pregabalin, lamotrigine, Depakote, topiramate, view more... Keppra, progesterone, Trileptal, oxcarbazepine, levetiracetam, Vimpat, phenobarbital